ARCHIVES

White House appoints NCI Director Andrew von Eschenbach acting FDA commissioner after Lester Crawford resigns.

This article is from The Cancer Letter archive.

Vol. 31 No. 35 | September 30, 2005

Download PDF Visit The Full Archive

Related Articles

New Approach To Replacing Immune Cells Shrinks Tumors

September 27, 2002

In Brief: Mass. Selects Hoh As Health Commissioner; Komen Foundation Selects Research Fellows

August 8, 1997

National Standards For Science Education Issued By Committee Led By NCI Director

December 15, 1995

Female Smokers Face Double Risk For Lung Cancer

July 28, 2006

Network Should Collect Some Environmental Information: Collins

August 9, 1996

Obituary: Michael Potter, 89, NIH Researcher

June 26, 2013